1. Home
  2. GILT vs BMEA Comparison

GILT vs BMEA Comparison

Compare GILT & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GILT
  • BMEA
  • Stock Information
  • Founded
  • GILT 1987
  • BMEA 2017
  • Country
  • GILT Israel
  • BMEA United States
  • Employees
  • GILT N/A
  • BMEA N/A
  • Industry
  • GILT Radio And Television Broadcasting And Communications Equipment
  • BMEA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GILT Technology
  • BMEA Health Care
  • Exchange
  • GILT Nasdaq
  • BMEA Nasdaq
  • Market Cap
  • GILT 281.1M
  • BMEA 275.6M
  • IPO Year
  • GILT 1993
  • BMEA 2021
  • Fundamental
  • Price
  • GILT $5.46
  • BMEA $8.33
  • Analyst Decision
  • GILT Strong Buy
  • BMEA Buy
  • Analyst Count
  • GILT 2
  • BMEA 13
  • Target Price
  • GILT $8.50
  • BMEA $37.25
  • AVG Volume (30 Days)
  • GILT 119.4K
  • BMEA 783.3K
  • Earning Date
  • GILT 11-13-2024
  • BMEA 10-29-2024
  • Dividend Yield
  • GILT N/A
  • BMEA N/A
  • EPS Growth
  • GILT 229.32
  • BMEA N/A
  • EPS
  • GILT 0.35
  • BMEA N/A
  • Revenue
  • GILT $292,248,000.00
  • BMEA N/A
  • Revenue This Year
  • GILT $26.84
  • BMEA N/A
  • Revenue Next Year
  • GILT $22.06
  • BMEA N/A
  • P/E Ratio
  • GILT $15.69
  • BMEA N/A
  • Revenue Growth
  • GILT 12.61
  • BMEA N/A
  • 52 Week Low
  • GILT $4.04
  • BMEA $3.61
  • 52 Week High
  • GILT $6.80
  • BMEA $22.74
  • Technical
  • Relative Strength Index (RSI)
  • GILT 72.81
  • BMEA 32.99
  • Support Level
  • GILT $5.06
  • BMEA $8.60
  • Resistance Level
  • GILT $5.58
  • BMEA $9.34
  • Average True Range (ATR)
  • GILT 0.11
  • BMEA 0.84
  • MACD
  • GILT 0.04
  • BMEA -0.46
  • Stochastic Oscillator
  • GILT 89.33
  • BMEA 0.64

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Share on Social Networks: